[1]Wong CM, Ng IO. Molecular pathogenesis of hepatocellular carcinoma [J]. Liver Int, 2008, 28(2): 160-174.
[2]Song P, Gao J, hagaki Y, et al. Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and China [J]. Liver Cancer, 2013, 2(1): 31-39.
[3]Tang ZY, Ye SL, Liu YK, et al. A decade’s studies on metastasis of hepatocellular carcinoma [J]. Cancer Res Clin Oncol, 2004, 130(4): 187-196.
[4]Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome [J]. Liver Transpl, 2004, 10(2 Suppl 1): S39-S45.
[5]Wang M, Huang ZhH, Lei P, et al. Proteomic profiling of N-linked glycoproteins involved in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry [J]. Chinese Journal of Biochemistry and Molecular Biology, 2013, 29 29(5): 482-489. (in Chinese)
王明, 黄志红, 雷鹏, 等. 二维电泳和质谱技术鉴定肝癌血清差异表达的N-连接糖蛋白[J]. 中国生物化学与分子生物学报, 2013, 29(5): 482-489.
[6]Ma J, Qi YJ, Liu RM, et al. Proteomic fingerprinting of N-linked glycoproteins involved in hepatocellular carcinoma [J]. Acta Anatomic Sinica, 2014, 45(4): 493-499. (in Chinese)
马瑾,齐义军,刘瑞敏,等. 肝细胞癌中差异表达N-连接糖蛋白的分析鉴定[J]. 解剖学报, 2014, 45(4): 493-499.
[7]Sun S, Xu MZ, Poon RT, et al. Circulating Lamin B1 (LMNB1 ) biomarker detects early stages of liver cancer in patients [J]. J Proteome Res, 2010, 9(1): 70-78.
[8]Bruix J, Sherman M. Management of hepatocellular carcinoma: an update [J]. Hepatology, 2011, 53(3): 1020-1022.
[9]Gatenby RA, Gillies RJ. Glycolysis in cancer: a potential target for therapy [J]. Int J Biochem Cell Biol, 2007, 39(78): 1358-1366.
[10]Klaunig JE, Xu Y, Isenberg JS, et al. The role of oxidative stress in chemical carcinogenesis [J]. Environ Health Perspect, 1998, 106 (Suppl 1): 289-295.
[11]Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion [J]. Cancer Metastasis Rev, 2009, 28(1-2): 15-33.
[12]Wu D, Guo Z, Min W, et al. Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability throughanti-apoptotic action of the protein [J]. Exp Ther Med, 2012, 3(3): 437-442.
[13]ChenYL,Yan MY, Chien SY, et al. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase-3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro [J]. Mol Med Rep, 2013, 7(5): 1487-1493.
[14]Zhang F, Liu B, Wang Z, et al. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression [J]. Mol Cancer Res, 2013, 11(12): 1508-1520.
[15]Kaarb ? M, Storm ML, Qu S, et al. TCTP is an androgen-regulated gene implicated in prostate cancer [J]. PLoS One, 2013, 8(7): e69398.
[16]Tuynder M, Susini L, Prieur S, et al. Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1 [J]. Proc Natl Acad Sci USA, 2002, 99(23): 14976-14981.
[17]Yu J. The role of epithelial cell adhesion molecule in the expression and metastasis of hepatocellular carcinoma [D]. Tianjin: Tianjie Medical School, 2010: 4-6. (in Chinese)
于娟.上皮细胞黏附分子在肝癌中的表达及转移中的作用[D].天津:天津医科大学,2010: 4-6.
[18]Pai RK, West RB. MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study [J]. Appl Immunohistochem Mol Morphol, 2009, 17(3): 202-206.
[19]Seimetz D, Lindhofer H, Bokemeyer C. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy [J]. Cancer Treat Res, 2010, 36(6): 458-467.
[20]Zhao P, Zhang W, Tang J, et al. Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147 [J]. Cancer Sci, 2010, 101(2): 387-395.
[21]Deng S, Wang J, Hou L, et al. Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically [J]. Oncol Lett, 2013, 5(1): 107-112.
[22]Gurluler E, Guner OS, Tumay LV, et al. Serum annexin A2 levels in patients with colon cancer in comparison to healthy controls and in relation to tumor pathology [J]. Med Sci Monit, 2014, 20: 1801-1807.
[23]Emoto K, Sawada H, Yamada Y, et al. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma [J]. Anticancer Res, 2001, 21(2B): 1339-1345.
[24]Zhai H, Acharya S, Gravanis I, et al. Annexin A2 promotes glioma cell invasion and tumor progression [J]. J Neurosci, 20115, 31(40): 14346-14360.
[25]Wang CY, Chen CL, Tseng YL, et al. Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms [J]. J Biol Chem, 2012, 287(39): 32512-32524.
[26]Zhang X, Liu S, Guo C, et al. The association of annexin A2 and cancers [J]. Clin Transl Oncol, 2012, 14(9): 634-640. |